Drug information for MYCOBUTIN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
150MG
Prescription
(Reference Drug)
RIFABUTIN
Rifabutin
PHARMACIA AND UPJOHN
50689
2008-06-05 Label
2008-05-14 Letter
2003-05-07 Label
2001-11-09 Letter
2001-11-09 Letter
Drug Adverse Effects information for MYCOBUTIN
Role code
Indications
Reaction
# Reports
PS
ATYPICAL MYCOBACTERIAL INFECTION
ATYPICAL MYCOBACTERIAL INFECTION
4
PS
ATYPICAL MYCOBACTERIAL INFECTION
GLAUCOMA
2
PS
ATYPICAL MYCOBACTERIAL INFECTION
PIGMENTATION DISORDER
2
PS
ATYPICAL MYCOBACTERIAL INFECTION
UVEITIS
6
PS
HELICOBACTER GASTRITIS
BONE MARROW DISORDER
1
PS
HELICOBACTER GASTRITIS
HEADACHE
1
PS
HELICOBACTER GASTRITIS
LEUKOPENIA
1
PS
HELICOBACTER GASTRITIS
PYREXIA
1
PS
HELICOBACTER GASTRITIS
THROMBOCYTOPENIA
1
SS
ATYPICAL MYCOBACTERIAL INFECTION
DRUG ERUPTION
6
SS
ATYPICAL MYCOBACTERIAL INFECTION
MALAISE
6
SS
ATYPICAL MYCOBACTERIAL INFECTION
PYREXIA
6
C
CYTOMEGALOVIRUS INFECTION
MYCOBACTERIAL INFECTION
2
C
HIV INFECTION
ATYPICAL MYCOBACTERIAL INFECTION
3
C
HIV INFECTION
IMMUNE RECONSTITUTION SYNDROME
3
C
HIV INFECTION
MYCOBACTERIAL INFECTION
8
C
PRODUCT USED FOR UNKNOWN INDICATION
ATYPICAL MYCOBACTERIAL INFECTION
5
C
PRODUCT USED FOR UNKNOWN INDICATION
IMMUNE RECONSTITUTION SYNDROME
5
Ads by Google